Table 2.

Breast cancer screening models currently represented in the CCGMC-WG2 Breast group.

Country or countries modelled	Model name	Reference
Australia	Policy1-breast	https://www.health.gov.au/sites/default/files/documents/2020/09/covid-19-scenario-modelling-for-cancer-screening-programs-the-breastscreen-australia-program.pdf
Canada	Oncosim	Yong, JHE, Nadeau, C, Flanagan, W, et al. the OncoSim-breast cancer microsimulation model. medRxiv. Epub ahead of print 2020. DOI: https://doi.org/10.1101/2020.05.22.20110569:2020.05.22.20110569.
The Netherlands	MISCAN (breast)	https://pubmed.ncbi.nlm.nih.gov/3849380 https://pubmed.ncbi.nlm.nih.gov/25895135/ https://pubmed.ncbi.nlm.nih.gov/32484237
The Netherlands	SiMRiSC	https://packages.debian.org/sid/simrisc https://pubmed.ncbi.nlm.nih.gov/19945279/ https://pubmed.ncbi.nlm.nih.gov/29452787/ https://pubmed.ncbi.nlm.nih.gov/32382844/
Australia, Scotland	Stage shift	https://www.medrxiv.org/content/10.1101/2020.05.30.20117630v1 https://cancerhealthservices.shinyapps.io/oncology_stage_shift/
United Kingdom	Life table model –breast cancer	https://jamanetwork.com/journals/jamaoncology/fullarticle/2686812
USA	CISNET (consortium of models applied to the US population)	https://cisnet.cancer.gov/publications/cancer-site.html#breast_header